Article Information
History
- February 8, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Julie Delorme*,1,
- Valentin Charvet*,2,3,
- Muriel Wartelle4,
- François Lion4,
- Bruno Thuillier5,
- Sandrine Mercier5,
- Jean-Charles Soria5,6,7,
- Mikael Azoulay4,
- Benjamin Besse6,7,
- Christophe Massard5,6,
- Antoine Hollebecque5 and
- Loic Verlingue□,5,6,8
- 1Institut Optique Graduate School, Paris, France
- 2Telecom Paris Tech, Paris, France
- 3Department of Computing Science, University of Glasgow, Glasgow G12 8RZ
- 4Informatic Team (DTNSI), Gustave Roussy, Villejuif, France
- 5Drug Development Department (DITEP), Gustave Roussy, Villejuif, France
- 6University Paris-Saclay, France
- 7Medical Oncology Department, Gustave Roussy, Villejuif, France
- 8INSERM UMR1030, Molecular Radiotherapy and Therapeutic Innovations, Gustave Roussy, Villejuif, France
- ↵□Corresponding author: Dr Loic Verlingue – Gustave Roussy Cancer Campus – 114 rue Edouard Vaillant – 94805 Villejuif Cedex – France – Tel: +33 1 42 11 63 50 – loic.verlingue{at}gustaveroussy.fr
↵* These authors have contributed equally to the study